Xponance Inc. Sells 242 Shares of Azenta, Inc. (NASDAQ:AZTA)

Xponance Inc. reduced its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 3.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 7,368 shares of the company’s stock after selling 242 shares during the quarter. Xponance Inc.’s holdings in Azenta were worth $480,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in AZTA. Federated Hermes Inc. raised its holdings in Azenta by 29.2% during the 4th quarter. Federated Hermes Inc. now owns 365,506 shares of the company’s stock worth $23,809,000 after purchasing an additional 82,502 shares during the last quarter. Citigroup Inc. grew its holdings in Azenta by 558.8% during the 3rd quarter. Citigroup Inc. now owns 88,078 shares of the company’s stock worth $4,421,000 after acquiring an additional 74,708 shares during the period. Millrace Asset Group Inc. bought a new position in shares of Azenta in the 3rd quarter worth about $1,074,000. Trexquant Investment LP acquired a new position in shares of Azenta in the 3rd quarter valued at about $860,000. Finally, Invesco Ltd. boosted its position in shares of Azenta by 35.4% during the 3rd quarter. Invesco Ltd. now owns 331,012 shares of the company’s stock valued at $16,613,000 after purchasing an additional 86,477 shares in the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. B. Riley increased their target price on shares of Azenta from $61.00 to $79.00 and gave the stock a “buy” rating in a research note on Thursday, February 1st. Stephens restated an “equal weight” rating and issued a $70.00 target price on shares of Azenta in a research note on Thursday, February 8th. Needham & Company LLC reaffirmed a “buy” rating and set a $75.00 price target on shares of Azenta in a research note on Monday, April 8th. Jefferies Financial Group initiated coverage on Azenta in a research note on Thursday, April 4th. They issued a “hold” rating and a $64.00 price objective for the company. Finally, Evercore ISI lowered their target price on Azenta from $64.00 to $60.00 and set an “in-line” rating on the stock in a research report on Thursday, April 4th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $69.60.

Azenta Stock Up 1.3 %

AZTA opened at $52.18 on Friday. The firm has a 50-day moving average price of $59.62 and a 200-day moving average price of $58.98. Azenta, Inc. has a twelve month low of $36.01 and a twelve month high of $69.16. The company has a market capitalization of $2.91 billion, a price-to-earnings ratio of -168.32 and a beta of 1.53.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings results on Wednesday, February 7th. The company reported $0.02 earnings per share for the quarter. Azenta had a positive return on equity of 0.49% and a negative net margin of 2.92%. The company had revenue of $154.32 million during the quarter, compared to analysts’ expectations of $151.86 million. On average, sell-side analysts expect that Azenta, Inc. will post 0.27 earnings per share for the current fiscal year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.